TNGX Tango Therapeutics, Inc.
$23.78▲ +1.75%
Healthcare
Other
After hours
$23.78▲ +0.00%
Sep 11, 7:30 PM ET
Volume 2.28M
Avg Volume (10D) 2.27M
Key Metrics & Fundamentals
Market Cap
$4.01B
P/E Ratio
–
Div Yield
–%
52W Range
6.38 - 34.39
% vs 50 MA
-10.23%
% vs 200 MA
19.55%
RSI-14
45.3
MACD Histogram
+0.1300
Beta (1Y vs SPY)
1.41
Free Cash Flow
-$38.87M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$59.36M
COGS
–
Operating Exp
$59.79M
Operating Income
-$59.79M
EBIT
-$59.79M
Pretax Income
-$55.34M
Net Income
-$55.34M
EPS (Diluted)
-0.37
Price & Volume History
Loading chart…
Recent News
Why Is Tango Therapeutics (TNGX) Down 6.2% Since Last Earnings Report?
Zacks · Sep 10, 2026 3:30 PM
Tango Therapeutics (TNGX) At 3.7x P B As Pullback Tests Whether It Looks Pricey
Simply Wall St. · Sep 4, 2026 7:08 AM
Tango Therapeutics Insider Sold Shares Worth $603,909, According to a Recent SEC Filing
MT Newswires · Sep 3, 2026 9:26 PM
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Sep 3, 2026 8:05 PM
Tango Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference
GlobeNewswire · Sep 1, 2026 11:00 AM
TNGX Stock Dips 5% as Q2 Earnings Miss Estimates on Higher Expenses
Zacks · Aug 12, 2026 2:46 PM
Tango Therapeutics Q2 Net Loss Widens
MT Newswires · Aug 11, 2026 11:40 AM
Tango Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights
GlobeNewswire · Aug 11, 2026 11:00 AM
Tango Therapeutics Executive Chair Barbara Weber Departs
MT Newswires · Aug 7, 2026 6:37 PM
Tango Therapeutics Announces Executive Chair Transition
GlobeNewswire · Aug 6, 2026 10:24 PM
Financial Overview - Income Statement
Quarterly
Sep 2025
See TNGX's money flow as a full page
Social Sentiment
Avg +0.80 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.